The Grizzly, February 28, 1986

Dormitory Damages are Repaired and Billed Immediately • Irish Gives Advice to Those in Job Market • Dean Whatley, There is a Parking Problem!!! • Letters: End Frat Prejudice; Case of Poor Taste; Where Were You on Thursday Night?; Pledging Plagues a Few • Alcohol Policy: A Case Study in the Liberal Arts Education • Student Volunteers Making a Difference at Norristown • Gramm-Rudman Will Hit U.C. • Epps not Opposed to Proposed Alcohol Policy • Parking: Still First Come First Served • Haverford Steals Show at MAC\u27s • Gymnasts Take Second at PAIAWs Breaking Team Scoring Record • The Lantern is Still Waiting for You • Little Known Ursinusiana • New Pipe Organ to be Installed in Bomberger • Aerobics: The Solution to Fat • Magnificent Noise • Campus Briefs: Faculty Bowled Over by Frontal Lobotomies; Wickersham to Speak at Classical Association; Open Dialog: Street People are Inevitable in a Free Society ; Spanish Student Finds New Home at Ursinus • Faculty Discusses Science for the Non-Scientific • Sculpture Exhibit by Klaus Ihlenfeldhttps://digitalcommons.ursinus.edu/grizzlynews/1159/thumbnail.jp

City of Hitchcock Comprehensive Plan 2020-2040

Hitchcock is a small town located in Galveston County (Figure 1.1), nestled up on the Texas Gulf Coast. It lies about 40 miles south-east of Houston. The boundaries of the city encloses an area of land of 60.46 sq. miles, an area of water of 31.64 sq. miles at an elevation just 16 feet above sea level. Hitchcock has more undeveloped land (~90% of total area) than the county combined. Its strategic location gives it a driving force of opportunities in the Houston-Galveston Region.The guiding principles for this planning process were Hitchcock’s vision statement and its corresponding goals, which were crafted by the task force. The goals focus on factors of growth and development including public participation, development considerations, transportation, community facilities, economic development, parks, and housing and social vulnerabilityTexas Target Communitie

Something New: Integrating the Etiological Role of Schadenfreude and Freudenfreude

This chapter summarizes research showing elevations of schadenfreude and diminished levels of freudenfreude to be common among those with depressive symptoms, suggesting a possible etiological role for these factors. The chapter also includes two replications of the Chambliss et al. (2012) study. These replications were conducted in Europe using samples of students and hospitalized patients diagnosed with depression, and both supported the previously observed link between elevated schadenfreude and depression. Furthermore, when the student and patient samples were combined, depression scores were found to be positively correlated with schadenfreude scores and negatively correlated with freudenfreude scores. The observed differences in schadenfreude and freudenfreude might contribute to the development of depression, be a consequence of it, or both. These studies provide important information about the crossculturally consistent nature of both the relationship between schadenfreude and depression as well as the relationship between freudenfreude and depression

The link between depression and schadenfreude: further evidence

This replication examined the link between schadenfreude (i.e., pleasure from another's misfortune), freudenfreude (i.e., pleasure from another's success), and self-rated depression. Using the Freudenfreude and Schadenfreude Test (FAST), moderately depressed students reported more schadenfreude and less freudenfreude than their mildly depressed peers. The limitations of this study and further research directions are discussed. </jats:p

Long term absence of invasive breast cancer diagnosis in 2,402,672 pre and postmenopausal women: A systematic review and meta-analysis.

BackgroundInvasive Breast Cancer (IBC) risk estimates continue to be based on data collated from cancer registries, i.e., retrospective research that excludes disease-free women. For women without a prior diagnosis, these estimates inflate both risk and screening frequency recommendations and inadvertently increase recently recognized harms from overdiagnosis and overtreatment.ObjectiveTo estimate the likelihood that pre or postmenopausal women with no prior diagnosis will remain free of IBC in order to enable evidence-based screening recommendations.MethodsProspective data from 21 studies of 2,402,672 women were analyzed, updating our previously published systematic search of 19 studies. This second systematic search included PubMed and The Cochrane Library from 2012 through April 2019. Inclusion criteria: only studies reporting the number of women enrolled, length of follow-up, and number of women diagnosed with IBC. Linear regression was used to estimate the percentage of women expected to remain free from an IBC diagnosis based on follow-up duration. To minimize non-response bias and selective outcome bias, only studies reporting outcomes for all enrolled women followed for similar, specific lengths of time were included. Sensitivity analyses confirm that the overall findings were unchanged by age at enrollment, menopausal status, screened women, variation in sample size, duration of follow-up, and heteroskedasticity.ResultsThe calculated percentage of women remaining IBC-free after follow-ups of 5, 10, 15, 20 and 25 years decreases uniformly by about one-fourth of one percent per year, i.e., 0.255% (95% CI: -0.29, -0.22; p ConclusionsOver 99.7% of pre/postmenopausal women with no prior diagnosis continued with no IBC each year, with 93.41% still free after 25 years. Our study supports the medical justification for reducing the frequency of mammograms for menopausal women with no prior IBC diagnosis

Invasive Breast Cancer Incidence in 2,305,427 Screened Asymptomatic Women: Estimated Long Term Outcomes during Menopause Using a Systematic Review

<div><p>Background</p><p>Earlier studies of breast cancer, screening mammography, and mortality reduction may have inflated lifetime and long-term risk estimates for invasive breast cancer due to limitations in their data collection methods and interpretation.</p><p>Objective</p><p>To estimate the percentage of asymptomatic peri/postmenopausal women who will be diagnosed with a first invasive breast cancer over their next 25 years of life.</p><p>Methods</p><p>A systematic review identified peer-reviewed published studies that: 1) enrolled no study participants with a history of invasive breast cancer; 2) specified the number of women enrolled; 3) reported the number of women diagnosed with a first invasive breast cancer; 4) did not overcount [count a woman multiple times]; and, 5) defined the length of follow-up. Data sources included PubMed, Cochrane Library, and an annotated library of 4,409 full-text menopause-related papers collected and reviewed by the first author from 1974 through 2008. Linear regression predicted incidence of first invasive breast cancer, based on follow-up duration in all studies that met the our inclusion criteria, and in a subset of these studies that included only women who were 1) at least 50 years old and 2) either at least 50 or less than 50 but surgically menopausal at enrollment.</p><p>Results</p><p>Nineteen studies met the inclusion criteria. They included a total of 2,305,427 peri/postmenopasual women. The mean cumulative incidence rate of first invasive breast cancer increased by 0.20% for each year of age (95% CI: 0.17, 0.23; p < 0.01; R² = 0.90). Over 25 years of follow-up, an estimated 94.55% of women will remain breast cancer-free (95% CI: 93.97, 95.13). In the 12 studies (n = 1,711,178) that enrolled only postmenopausal women, an estimated 0.23% of women will be diagnosed with a first invasive breast cancer each year (95% CI: 0.18, 0.28; p < 0.01, R² = 0.88).</p><p>Conclusion</p><p>The vast majority (99.75%) of screened asymptomatic peri/postmenopasual women will not be diagnosed with invasive breast cancer each year. Approximately 95% will not be diagnosed with invasive breast cancer during 25 years of follow-up. Women who receive clinical examinations, but do not have mammograms, will have higher cancer-free rates because innocuous positives (comprising 30-50% of mammography diagnoses) will remain undetected. Informed consent to asymptomatic women should include these results and consideration of the benefits of avoiding mammograms.</p></div

Scatterplot and regression with 95% CI for the relationship between cumulative incidence of invasive breast cancer and duration of follow-up from the 19 studies of peri/postmenopausal women.

<p>Based on all 19 studies, each plotted point is located at the intersection of the study duration and its cumulative incidence of invasive breast cancer. To focus attention on the 13% lifetime risk estimate currently advertised, the maximum of the X-axis is set at 13%.</p